Algo version: 0.98b
Grape King Bio Ltd is listed at the TAI Exchange
Grape King Bio Ltd [1707.TW]
TAI Sector: Healthcare Industry:Drug Manufacturers—Specialty & Generic

Is Grape King Bio Ltd stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

Yes, Grape King Bio Ltd pays dividends. Last time was Thursday 18th of July 2024 where the investors holding the stock on Thursday 20th of June 2024 were paid TWD6.9 per share. Over the last 20 times between 2005 and 2024, Grape King Bio Ltd has paid TWD83.4697 with an average of TWD4.17 per share.

Sorry, we do not have any analyst data for this ticker

We cannot find data for Grape King Bio Ltd 10 years ago, but if you had invested on Monday 9th of September 2019 when the price was TWD187.50, you would have made a loss of TWD-44.00 per share or -23.47%

Yes, the average daily trading liquidity for Grape King Bio Ltd is TWD364 876 thousand. You should therefore be able to get in and out of your positions relatively fast.

Grape King Bio Ltd has no real debt, which is good in periods of high inflation. With a high cash flow to debt ratio of 13.72, the company's ability to pay off the debt is good. Grape King Bio Ltd has a good net profit margin of 13.29% and should have high tolerances against inflation.

We have calculated the inflation risk for Grape King Bio Ltd to be low [0.1 of 1]

US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.